Christopher Mills - Bioquell plc Insider

BIQLF -- USA Stock  

USD 3.50  0.00  0.00%

Non-Executive Director

Mr. Christopher Harwood Bernard Mills is an Independent NonExecutive Director of Bioquell PLC., since December 18, 2012. He Joined the Board in December 2012. He is Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC, a director of Oryx International Growth Fund Ltd and is the Chief Investment Officer and a member of Harwood Capital LLP.
Age: 63  Director Since 2012      
44 1264 835 900
Mills is also a director of Sunlink Health Systems Inc, Bionostics Holdings Limited, Hampton Investment Properties, Second London American Trust PLC, Glass America, Inc, Progeny, Inc, Global Options, Celsis International Limited and MJ Gleeson PLC.

Christopher Mills Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 5.32 % which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.16 % meaning that it generated $5.16 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

Bioquell PLC designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc is traded on OTC Market in USA.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 200 people.

Bioquell plc Leadership Team

Ian Johnson, Chairman
Nigel Keen, Chairman
Nicholas Adams, Director
Christopher Mills, Director
Anthony Bourne, Director
Georgina Pope, Executive
Michael Roller, Director
Ian Carruthers, Director
Simon Constantine, Director

Stock Performance Indicators

Current Sentiment - BIQLF

Bioquell plc Investor Sentiment
Macroaxis portfolio users are unresponsive in their opinion about investing in Bioquell plc. What is your opinion about investing in Bioquell plc? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Bioquell plc and Facebook. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.